Blood stem cell transplantation

Factors influencing cellular immunological reconstitution

John G Sharp, A. Kessinger, J. C. Lynch, Z. S. Pavletic, Shantaram S Joshi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Recovery of immune function following stem cell transplantation is necessary for a good outcome. Immune recovery is facilitated by transplanting higher numbers of cells than neutrophil or platelet reconstitution requires. Estimates from studies in the allogeneic setting suggest the minimum stem cell dose to achieve optimal lymphocyte recovery is about 107 CD34+ cells/kg. Increasing the number of autologous stem cells infused potentially increases the risk of reinfusing tumor cells. Transplanted mature immune cells apparently have very limited early contribution to cellular immune recovery. Mobilizing cytokines permit collection of greater numbers of stem cells, but they also can polarize T cells with potentially significant consequences, for example, granulocyte colony-stimulating factor (G-CSF) decreases the antitumor cytotoxic effector functions of cells. Although this could be a disadvantage in the autologous setting, it might decrease graft versus host disease in the allogeneic setting. Thus, identification of cytokines, which alone or in combination provide the most potent mobilizing effect to permit the collection of the highest number of stem cells without inadvertent detrimental polarization of the responses of immune cells, and employment of cytokines post-transplantation, which direct differentiation of the stem cells along the most desirable pathways, for example, to generate antitumor immune responses, might improve immunological outcome. A future emphasis should be to better define the cytokines and target cell populations that provide optimal immune reconstitution rather than focusing solely on rapid hematological recovery. More complete immunological reconstitution in a greater proportion of patients should be accompanied by improvements in outcomes of blood stem cell transplantation.

Original languageEnglish (US)
Pages (from-to)971-981
Number of pages11
JournalJournal of Hematotherapy and Stem Cell Research
Volume9
Issue number6
DOIs
StatePublished - Dec 1 2000

Fingerprint

Stem Cell Factor
Stem Cell Transplantation
Blood Cells
Stem Cells
Cytokines
Health Services Needs and Demand
Recovery of Function
Graft vs Host Disease
Granulocyte Colony-Stimulating Factor
Platelet Count
Neutrophils
Cell Count
Transplantation
Lymphocytes
T-Lymphocytes
Neoplasms

ASJC Scopus subject areas

  • Immunology
  • Hematology

Cite this

Blood stem cell transplantation : Factors influencing cellular immunological reconstitution. / Sharp, John G; Kessinger, A.; Lynch, J. C.; Pavletic, Z. S.; Joshi, Shantaram S.

In: Journal of Hematotherapy and Stem Cell Research, Vol. 9, No. 6, 01.12.2000, p. 971-981.

Research output: Contribution to journalArticle

@article{ef11d6309d944099bf4d88fcbea58a9f,
title = "Blood stem cell transplantation: Factors influencing cellular immunological reconstitution",
abstract = "Recovery of immune function following stem cell transplantation is necessary for a good outcome. Immune recovery is facilitated by transplanting higher numbers of cells than neutrophil or platelet reconstitution requires. Estimates from studies in the allogeneic setting suggest the minimum stem cell dose to achieve optimal lymphocyte recovery is about 107 CD34+ cells/kg. Increasing the number of autologous stem cells infused potentially increases the risk of reinfusing tumor cells. Transplanted mature immune cells apparently have very limited early contribution to cellular immune recovery. Mobilizing cytokines permit collection of greater numbers of stem cells, but they also can polarize T cells with potentially significant consequences, for example, granulocyte colony-stimulating factor (G-CSF) decreases the antitumor cytotoxic effector functions of cells. Although this could be a disadvantage in the autologous setting, it might decrease graft versus host disease in the allogeneic setting. Thus, identification of cytokines, which alone or in combination provide the most potent mobilizing effect to permit the collection of the highest number of stem cells without inadvertent detrimental polarization of the responses of immune cells, and employment of cytokines post-transplantation, which direct differentiation of the stem cells along the most desirable pathways, for example, to generate antitumor immune responses, might improve immunological outcome. A future emphasis should be to better define the cytokines and target cell populations that provide optimal immune reconstitution rather than focusing solely on rapid hematological recovery. More complete immunological reconstitution in a greater proportion of patients should be accompanied by improvements in outcomes of blood stem cell transplantation.",
author = "Sharp, {John G} and A. Kessinger and Lynch, {J. C.} and Pavletic, {Z. S.} and Joshi, {Shantaram S}",
year = "2000",
month = "12",
day = "1",
doi = "10.1089/152581600750062435",
language = "English (US)",
volume = "9",
pages = "971--981",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Blood stem cell transplantation

T2 - Factors influencing cellular immunological reconstitution

AU - Sharp, John G

AU - Kessinger, A.

AU - Lynch, J. C.

AU - Pavletic, Z. S.

AU - Joshi, Shantaram S

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Recovery of immune function following stem cell transplantation is necessary for a good outcome. Immune recovery is facilitated by transplanting higher numbers of cells than neutrophil or platelet reconstitution requires. Estimates from studies in the allogeneic setting suggest the minimum stem cell dose to achieve optimal lymphocyte recovery is about 107 CD34+ cells/kg. Increasing the number of autologous stem cells infused potentially increases the risk of reinfusing tumor cells. Transplanted mature immune cells apparently have very limited early contribution to cellular immune recovery. Mobilizing cytokines permit collection of greater numbers of stem cells, but they also can polarize T cells with potentially significant consequences, for example, granulocyte colony-stimulating factor (G-CSF) decreases the antitumor cytotoxic effector functions of cells. Although this could be a disadvantage in the autologous setting, it might decrease graft versus host disease in the allogeneic setting. Thus, identification of cytokines, which alone or in combination provide the most potent mobilizing effect to permit the collection of the highest number of stem cells without inadvertent detrimental polarization of the responses of immune cells, and employment of cytokines post-transplantation, which direct differentiation of the stem cells along the most desirable pathways, for example, to generate antitumor immune responses, might improve immunological outcome. A future emphasis should be to better define the cytokines and target cell populations that provide optimal immune reconstitution rather than focusing solely on rapid hematological recovery. More complete immunological reconstitution in a greater proportion of patients should be accompanied by improvements in outcomes of blood stem cell transplantation.

AB - Recovery of immune function following stem cell transplantation is necessary for a good outcome. Immune recovery is facilitated by transplanting higher numbers of cells than neutrophil or platelet reconstitution requires. Estimates from studies in the allogeneic setting suggest the minimum stem cell dose to achieve optimal lymphocyte recovery is about 107 CD34+ cells/kg. Increasing the number of autologous stem cells infused potentially increases the risk of reinfusing tumor cells. Transplanted mature immune cells apparently have very limited early contribution to cellular immune recovery. Mobilizing cytokines permit collection of greater numbers of stem cells, but they also can polarize T cells with potentially significant consequences, for example, granulocyte colony-stimulating factor (G-CSF) decreases the antitumor cytotoxic effector functions of cells. Although this could be a disadvantage in the autologous setting, it might decrease graft versus host disease in the allogeneic setting. Thus, identification of cytokines, which alone or in combination provide the most potent mobilizing effect to permit the collection of the highest number of stem cells without inadvertent detrimental polarization of the responses of immune cells, and employment of cytokines post-transplantation, which direct differentiation of the stem cells along the most desirable pathways, for example, to generate antitumor immune responses, might improve immunological outcome. A future emphasis should be to better define the cytokines and target cell populations that provide optimal immune reconstitution rather than focusing solely on rapid hematological recovery. More complete immunological reconstitution in a greater proportion of patients should be accompanied by improvements in outcomes of blood stem cell transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0034485744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034485744&partnerID=8YFLogxK

U2 - 10.1089/152581600750062435

DO - 10.1089/152581600750062435

M3 - Article

VL - 9

SP - 971

EP - 981

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 6

ER -